Opening Ceremony for Mitsui Chemicals Singapore R&D Centre
-Intensifying Overseas R&D Functions-
September 9, 2011
Mitsui Chemicals,Inc.
Mitsui Chemicals, Inc. (MCI), with its head office in Tokyo, Japan (Toshikazu Tanaka, President & CEO), will hold a ceremony today at The Japanese Association in Singapore to commemorate opening of the Mitsui Chemicals Singapore R&D Centre (MS-R&D) which was established as part of the company's fundamental management strategy for globalization.
Leading Singapore government officials, including Mr. Lim Chuan Poh, Chairman of the Agency for Science, Technology and Research (A*Star), Mr. Tan Choon Shian, Deputy Managing Director of the Economic Development Board (EDB), Japanese government officials, and other distinguished guests are expected to attend the event.
Singapore is a top player in the ever growing Asian chemical market and offers world-class access to strategic markets. The Mitsui Chemicals Group has 15 companies in ASEAN countries and India, and positions Singapore as an important production and sales base in its global business.
Currently, the Group has three companies in the country (see note). This April, head office operations for the high performance elastomer TAFMER™, in which MCI holds the world's top share, were transferred to its subsidiary in Singapore.
Additionally, the government offers many advantages to support relocation of R&D facilities to the country in an effort to become the Asian hub for R&D activity. World-class researchers have followed companies opening up state-of-the-art research facilities in Singapore.
In 2006, MCI established a technical centre under its regional management company, Mitsui Chemicals Asia Pacific, Ltd., where together with A*Star, it conducted research on catalysis science and technology.
Building on the already good relationship with the Singapore government and to intensify independence of the Group's overseas R&D functions, MCI established a new R&D company in Singapore. The company has high expectations for Singapore's outstanding R&D potential and will reinforce its R&D operations by tapping into the country's outstanding human resources.
MS-R&D will have three functions and focus on development themes which will benefit from the country's strategic location.
- Conjoining of R&D with business model development to enhance new business opportunities.
- Market development by accelerating information access on the rapidly growing demand in the Asian market.
- Development and strengthening of MCI's human resources base.
Through the new MS-R&D, the company targets intensifying its R&D activities, in line with fundamental strategies of the 2011 Mid-Term Business Plan, developing next generation core business, accelerating globalization, and enhancing its business presence in Asia.
Outline of Mitsui Chemicals Singapore R&D Centre
| 1. Company name: | Mitsui Chemicals Singapore R&D Centre Pte Ltd. |
| 2. Establishment: | May 1, 2011 |
| 3. Capital: | US$ 7 million (approximately 600 million yen) |
| 4. Investment ratio: | 100% Mitsui Chemicals |
| 5. Location: | Science Park Ⅱ Kendall Bldg.6F 50 Science Park Road, #06-08 The Kendall Singapore Science Park Ⅱ, Singapore 117406 Tel +65－6570－5730 Fax +65－6778－0843 |
| 6. Managing Director: | Terunori Fujita (Executive Officer, Mitsui Chemicals, Inc.) |
| 7. Business: | Research and development for the MCI Group (contract base) |
Note: Mitsui Chemicals Group Production and Sales Companies in Singapore
・Mitsui Chemicals Asia Pacific, Ltd.
・Mitsui Phenols Singapore, Pte, Ltd.
・Mitsui Elastomers Singapore, Pte, Ltd.
Attachment
Opening Ceremony for Mitsui Chemicals Singapore R&D Centre (PDF:141KB)
